Home / Cancer and immune system / Letrozole
ATC L02BG04 · Endocrine Therapy
Letrozole shortage
As of 31 Oct 2026, Letrozole has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 4 products.
Countries2/5
Products4packs or presentations
Short since26 Jun 20264 months ago
Earliest return6 Nov 2026company estimate
No return date1products
Main reasonIncreased demand
Timeline
ItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ZOLOBREST | ACCORD HEALTHCARE, S.L.U. | 19 Oct 2026 | not given | Increased demand Elevata richiesta |
| BE | Letrozol Sandoz 2.5 mg film-coat. tabl. 30 | Sandoz | 26 Jun 2026 | 6 Nov 2026 | Increased demand |
| BE | Letrozole Teva 2.5 mg film-coat. tabl. 30 | Teva | 26 Oct 2026 | 18 Jan 2027 | Increased demand |
| BE | Letrozole EG 2.5 mg (PI Pharma) film-coat. tabl. 100 | PI Pharma | 29 Oct 2026 | 30 Nov 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.